Rubius Therapeutics, Inc.
USD0.06
+0.00 (+2.70%)
CEO
Laurence A. Turka
IPO Date
2018-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.06
Prev. Close
$0.06
Day Low
$0.06
Day High
$0.06
52W Low
$0.00
52W High
$0.38
Volume
0.76M
| -4.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -114.5% | -58.3% | 0.82 | 6.52 | -3.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -58.5% | -40.6% | 0.35 | 8.57 | -4.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -22.7% | -18.6% | 0.18 | 20.72 | -12.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 100.4% | -40.7% | -0.12 | 14.67 | -4.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 64.3% | -137.9% | -0.23 | 2.41 | -18.8 |
| -0.1 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -47.7% | -19.9% | 1.17 | 4.63 | -0.4 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -40.1% | -20.2% | 0.84 | 6.23 | -2.3 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -30.8% | -17.3% | 0.63 | 6.63 | -4.0 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -21.9% | -13.6% | 0.51 | 8.74 | -8.2 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -19.0% | -12.7% | 0.44 | 12.12 | -10.9 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -14.1% | -9.8% | 0.39 | 10.96 | -12.9 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | -28.6% | -14.6% | 0.82 | 6.52 | -3.8 |
| 30 Sept 2020 | Q3 | 0.0% | 0.0% | -23.6% | -13.1% | 0.68 | 7.15 | -2.5 |